EE+ POEM Archive
Rifampin for 4 months preferred to isoniazid for 9 months for latent TB in high-risk patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Rifampin for 4 Months Preferred to Isoniazid for 9 Months for Latent TB in High-risk Patients." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314628/all/Rifampin_for_4_months_preferred_to_isoniazid_for_9_months_for_latent_TB_in_high_risk_patients.
Rifampin for 4 months preferred to isoniazid for 9 months for latent TB in high-risk patients. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314628/all/Rifampin_for_4_months_preferred_to_isoniazid_for_9_months_for_latent_TB_in_high_risk_patients. Accessed April 25, 2024.
Rifampin for 4 months preferred to isoniazid for 9 months for latent TB in high-risk patients. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314628/all/Rifampin_for_4_months_preferred_to_isoniazid_for_9_months_for_latent_TB_in_high_risk_patients
Rifampin for 4 Months Preferred to Isoniazid for 9 Months for Latent TB in High-risk Patients [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314628/all/Rifampin_for_4_months_preferred_to_isoniazid_for_9_months_for_latent_TB_in_high_risk_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifampin for 4 months preferred to isoniazid for 9 months for latent TB in high-risk patients
ID - 1314628
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314628/all/Rifampin_for_4_months_preferred_to_isoniazid_for_9_months_for_latent_TB_in_high_risk_patients
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
